Patoloxía Molecular das Doenzas Raras
PatMol-DR
![Foto de Patoloxía Molecular das Doenzas Raras](/img/grupo.png)
![Foto de Universidad de Navarra](/img/noimage_org.png)
Universidad de Navarra
Pamplona, EspañaPublicacións en colaboración con investigadores/as de Universidad de Navarra (9)
2021
-
Long-term prognosis of women with Brugada syndrome and electrophysiological study
Heart Rhythm, Vol. 18, Núm. 5, pp. 664-671
2019
-
Quantitative assessment of left ventricular size and function in cardiac transplant recipients: Side-by-side comparison of real time two-dimensional echocardiography, contrast-enhanced two-dimensional echocardiography, three-dimensional echocardiography, and contrast-enhanced three-dimensional echocardiography as compared to magnetic resonance imaging
Echocardiography, Vol. 36, Núm. 2, pp. 306-311
2018
-
Innovative Strategies in Heart Failure: Present and Future
Archives of Medical Research, Vol. 49, Núm. 8, pp. 558-567
-
Long-term prognosis of patients with life-threatening ventricular arrhythmias induced by coronary artery spasm
Europace, Vol. 20, Núm. 5, pp. 851-858
-
Matrix metalloproteinase-10 deficiency delays atherosclerosis progression and plaque calcification
Atherosclerosis, Vol. 278, pp. 124-134
2016
-
Monomorphic ventricular tachycardia in patients with Brugada syndrome: A multicenter retrospective study
Heart Rhythm, Vol. 13, Núm. 3, pp. 669-682
2015
-
T-Wave Oversensing in Patients with Brugada Syndrome: True Bipolar Versus Integrated Bipolar Implantable Cardioverter Defibrillator Leads
Circulation: Arrhythmia and Electrophysiology, Vol. 8, Núm. 4, pp. 792-798
-
Targeting γ-secretases protect against angiotensin II-induced cardiac hypertrophy
Journal of Hypertension
1992
-
DIURETICOS E HIPERTROFIA VENTRICULAR IZQUIERDA [2]
Medicina Clinica